nodes	percent_of_prediction	percent_of_DWPC	metapath
Cytarabine—DCTD—Pyrimidine biosynthesis—TYMS—rectum cancer	0.0853	0.148	CbGpPWpGaD
Cytarabine—POLB—Base-free sugar-phosphate removal via the single-nucleotide replacement pathway—SMUG1—rectum cancer	0.0602	0.104	CbGpPWpGaD
Cytarabine—POLB—Resolution of AP sites via the single-nucleotide replacement pathway—SMUG1—rectum cancer	0.052	0.0901	CbGpPWpGaD
Cytarabine—POLB—Removal of DNA patch containing abasic residue—SMUG1—rectum cancer	0.0394	0.0682	CbGpPWpGaD
Cytarabine—POLB—Base Excision Repair—SMUG1—rectum cancer	0.036	0.0624	CbGpPWpGaD
Cytarabine—DCTD—Pyrimidine metabolism—TYMS—rectum cancer	0.0281	0.0487	CbGpPWpGaD
Cytarabine—NT5E—Pyrimidine metabolism—TYMS—rectum cancer	0.0162	0.028	CbGpPWpGaD
Cytarabine—POLD1—Removal of DNA patch containing abasic residue—SMUG1—rectum cancer	0.0151	0.0261	CbGpPWpGaD
Cytarabine—DCTD—seminal vesicle—rectum cancer	0.0151	0.0366	CbGeAlD
Cytarabine—CDA—Pyrimidine metabolism—TYMS—rectum cancer	0.0148	0.0256	CbGpPWpGaD
Cytarabine—CDA—Fluoropyrimidine Activity—SMUG1—rectum cancer	0.0143	0.0248	CbGpPWpGaD
Cytarabine—POLD1—Base Excision Repair—SMUG1—rectum cancer	0.0138	0.0239	CbGpPWpGaD
Cytarabine—DCTD—smooth muscle tissue—rectum cancer	0.0126	0.0306	CbGeAlD
Cytarabine—POLD1—renal system—rectum cancer	0.0123	0.0299	CbGeAlD
Cytarabine—DCTD—renal system—rectum cancer	0.0121	0.0295	CbGeAlD
Cytarabine—POLB—female reproductive system—rectum cancer	0.0121	0.0293	CbGeAlD
Cytarabine—DCTD—urethra—rectum cancer	0.0119	0.0289	CbGeAlD
Cytarabine—CDA—Fluoropyrimidine Activity—TYMS—rectum cancer	0.0115	0.0198	CbGpPWpGaD
Cytarabine—POLE—seminal vesicle—rectum cancer	0.0114	0.0277	CbGeAlD
Cytarabine—DCTD—mammalian vulva—rectum cancer	0.0113	0.0275	CbGeAlD
Cytarabine—DCTD—Nucleotide metabolism—TYMS—rectum cancer	0.011	0.019	CbGpPWpGaD
Cytarabine—POLB—vagina—rectum cancer	0.0109	0.0265	CbGeAlD
Cytarabine—Gemcitabine—TYMS—rectum cancer	0.0105	1	CrCbGaD
Cytarabine—SLC22A2—Amine compound SLC transporters—SLC14A2—rectum cancer	0.0104	0.0181	CbGpPWpGaD
Cytarabine—CDA—mammalian vulva—rectum cancer	0.0103	0.0251	CbGeAlD
Cytarabine—NT5E—epithelium—rectum cancer	0.0101	0.0246	CbGeAlD
Cytarabine—SLC29A1—Fluoropyrimidine Activity—SMUG1—rectum cancer	0.00992	0.0172	CbGpPWpGaD
Cytarabine—POLD1—female reproductive system—rectum cancer	0.00985	0.0239	CbGeAlD
Cytarabine—POLA1—seminal vesicle—rectum cancer	0.00984	0.0239	CbGeAlD
Cytarabine—NT5E—smooth muscle tissue—rectum cancer	0.00975	0.0237	CbGeAlD
Cytarabine—SLC22A1—Amine compound SLC transporters—SLC14A2—rectum cancer	0.00973	0.0168	CbGpPWpGaD
Cytarabine—DCTD—female reproductive system—rectum cancer	0.00972	0.0236	CbGeAlD
Cytarabine—NT5E—renal system—rectum cancer	0.00939	0.0228	CbGeAlD
Cytarabine—NT5E—urethra—rectum cancer	0.00922	0.0224	CbGeAlD
Cytarabine—POLE—urethra—rectum cancer	0.00903	0.0219	CbGeAlD
Cytarabine—DCTD—vagina—rectum cancer	0.00879	0.0213	CbGeAlD
Cytarabine—NT5E—mammalian vulva—rectum cancer	0.00878	0.0213	CbGeAlD
Cytarabine—POLB—DNA Repair—SMUG1—rectum cancer	0.00865	0.015	CbGpPWpGaD
Cytarabine—DCK—Pyrimidine metabolism—TYMS—rectum cancer	0.00862	0.0149	CbGpPWpGaD
Cytarabine—POLE—mammalian vulva—rectum cancer	0.0086	0.0209	CbGeAlD
Cytarabine—POLA1—G1/S-Specific Transcription—TYMS—rectum cancer	0.00832	0.0144	CbGpPWpGaD
Cytarabine—CDA—vagina—rectum cancer	0.008	0.0194	CbGeAlD
Cytarabine—SLC29A1—Fluoropyrimidine Activity—TYMS—rectum cancer	0.00794	0.0138	CbGpPWpGaD
Cytarabine—POLA1—urethra—rectum cancer	0.00779	0.0189	CbGeAlD
Cytarabine—NT5E—female reproductive system—rectum cancer	0.00752	0.0182	CbGeAlD
Cytarabine—POLA1—mammalian vulva—rectum cancer	0.00741	0.018	CbGeAlD
Cytarabine—POLE—female reproductive system—rectum cancer	0.00737	0.0179	CbGeAlD
Cytarabine—POLB—lymph node—rectum cancer	0.00705	0.0171	CbGeAlD
Cytarabine—NT5E—vagina—rectum cancer	0.0068	0.0165	CbGeAlD
Cytarabine—POLE—vagina—rectum cancer	0.00666	0.0162	CbGeAlD
Cytarabine—NT5E—Nucleotide metabolism—TYMS—rectum cancer	0.0063	0.0109	CbGpPWpGaD
Cytarabine—DCK—seminal vesicle—rectum cancer	0.00607	0.0147	CbGeAlD
Cytarabine—SLC22A2—renal system—rectum cancer	0.0059	0.0143	CbGeAlD
Cytarabine—ABCC10—seminal vesicle—rectum cancer	0.00578	0.014	CbGeAlD
Cytarabine—POLD1—lymph node—rectum cancer	0.00576	0.014	CbGeAlD
Cytarabine—CDA—Nucleotide metabolism—TYMS—rectum cancer	0.00576	0.00997	CbGpPWpGaD
Cytarabine—POLA1—vagina—rectum cancer	0.00574	0.0139	CbGeAlD
Cytarabine—DCTD—lymph node—rectum cancer	0.00569	0.0138	CbGeAlD
Cytarabine—SLC29A1—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.00556	0.00964	CbGpPWpGaD
Cytarabine—CDA—lymph node—rectum cancer	0.00517	0.0126	CbGeAlD
Cytarabine—SLC29A1—renal system—rectum cancer	0.00512	0.0124	CbGeAlD
Cytarabine—SLC29A1—urethra—rectum cancer	0.00503	0.0122	CbGeAlD
Cytarabine—POLA1—E2F mediated regulation of DNA replication—TYMS—rectum cancer	0.00489	0.00847	CbGpPWpGaD
Cytarabine—DCK—urethra—rectum cancer	0.0048	0.0117	CbGeAlD
Cytarabine—SLC29A1—mammalian vulva—rectum cancer	0.00478	0.0116	CbGeAlD
Cytarabine—ABCC10—renal system—rectum cancer	0.00466	0.0113	CbGeAlD
Cytarabine—ABCC10—urethra—rectum cancer	0.00457	0.0111	CbGeAlD
Cytarabine—DCK—mammalian vulva—rectum cancer	0.00457	0.0111	CbGeAlD
Cytarabine—NT5E—lymph node—rectum cancer	0.0044	0.0107	CbGeAlD
Cytarabine—ABCC10—mammalian vulva—rectum cancer	0.00435	0.0106	CbGeAlD
Cytarabine—POLE—lymph node—rectum cancer	0.00431	0.0105	CbGeAlD
Cytarabine—POLE—Mitotic M-M/G1 phases—RAB1A—rectum cancer	0.0042	0.00728	CbGpPWpGaD
Cytarabine—SLC22A1—renal system—rectum cancer	0.00417	0.0101	CbGeAlD
Cytarabine—SLC29A1—female reproductive system—rectum cancer	0.0041	0.00994	CbGeAlD
Cytarabine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—rectum cancer	0.00408	0.00707	CbGpPWpGaD
Cytarabine—DCK—female reproductive system—rectum cancer	0.00391	0.0095	CbGeAlD
Cytarabine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—rectum cancer	0.0038	0.00659	CbGpPWpGaD
Cytarabine—CDA—Fluoropyrimidine Activity—TP53—rectum cancer	0.0038	0.00658	CbGpPWpGaD
Cytarabine—ABCC10—female reproductive system—rectum cancer	0.00373	0.00905	CbGeAlD
Cytarabine—POLA1—lymph node—rectum cancer	0.00371	0.00901	CbGeAlD
Cytarabine—SLC29A1—vagina—rectum cancer	0.00371	0.00899	CbGeAlD
Cytarabine—ABCC10—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00357	0.00618	CbGpPWpGaD
Cytarabine—DCK—vagina—rectum cancer	0.00354	0.00859	CbGeAlD
Cytarabine—ABCC10—vagina—rectum cancer	0.00337	0.00819	CbGeAlD
Cytarabine—DCK—Nucleotide metabolism—TYMS—rectum cancer	0.00336	0.00582	CbGpPWpGaD
Cytarabine—POLD1—DNA Repair—SMUG1—rectum cancer	0.00332	0.00574	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—RAB1A—rectum cancer	0.00325	0.00564	CbGpPWpGaD
Cytarabine—POLE—DNA Repair—SMUG1—rectum cancer	0.0032	0.00555	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—TYMS—rectum cancer	0.00316	0.00547	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—RAB1A—rectum cancer	0.00314	0.00544	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—TYMS—rectum cancer	0.00308	0.00533	CbGpPWpGaD
Cytarabine—SLC22A1—vagina—rectum cancer	0.00302	0.00733	CbGeAlD
Cytarabine—POLA1—Mitotic M-M/G1 phases—RAB1A—rectum cancer	0.00299	0.00519	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—RAB1A—rectum cancer	0.00291	0.00504	CbGpPWpGaD
Cytarabine—SLC29A1—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.00283	0.0049	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—RAB1A—rectum cancer	0.00281	0.00487	CbGpPWpGaD
Cytarabine—POLE—G1/S Transition—TYMS—rectum cancer	0.00264	0.00457	CbGpPWpGaD
Cytarabine—SLC29A1—Fluoropyrimidine Activity—TP53—rectum cancer	0.00263	0.00456	CbGpPWpGaD
Cytarabine—POLA1—E2F transcription factor network—TYMS—rectum cancer	0.00259	0.00449	CbGpPWpGaD
Cytarabine—SLC29A1—lymph node—rectum cancer	0.0024	0.00582	CbGeAlD
Cytarabine—DCK—lymph node—rectum cancer	0.00229	0.00556	CbGeAlD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—TYMS—rectum cancer	0.00225	0.0039	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—RAB1A—rectum cancer	0.00224	0.00388	CbGpPWpGaD
Cytarabine—POLE—Mitotic G1-G1/S phases—TYMS—rectum cancer	0.00222	0.00385	CbGpPWpGaD
Cytarabine—ABCC10—lymph node—rectum cancer	0.00218	0.00529	CbGeAlD
Cytarabine—POLA1—Cell Cycle—RAB1A—rectum cancer	0.002	0.00347	CbGpPWpGaD
Cytarabine—CYP3A4—renal system—rectum cancer	0.0019	0.00461	CbGeAlD
Cytarabine—POLA1—G1/S Transition—TYMS—rectum cancer	0.00188	0.00326	CbGpPWpGaD
Cytarabine—SLC22A2—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.00185	0.00321	CbGpPWpGaD
Cytarabine—SLC22A1—SLC-mediated transmembrane transport—SLC14A2—rectum cancer	0.00173	0.00299	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—TYMS—rectum cancer	0.00158	0.00274	CbGpPWpGaD
Cytarabine—CYP3A4—female reproductive system—rectum cancer	0.00152	0.00369	CbGeAlD
Cytarabine—POLE—G1 to S cell cycle control—TP53—rectum cancer	0.00128	0.00221	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TYMS—rectum cancer	0.0012	0.00208	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—TP53—rectum cancer	0.00105	0.00182	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—rectum cancer	0.00102	0.00177	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—TYMS—rectum cancer	0.000996	0.00172	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000942	0.00163	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—SLC14A2—rectum cancer	0.000878	0.00152	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—TYMS—rectum cancer	0.000845	0.00146	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—TYMS—rectum cancer	0.000816	0.00141	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TYMS—rectum cancer	0.000755	0.00131	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—rectum cancer	0.000747	0.00129	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TYMS—rectum cancer	0.000729	0.00126	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—TYMS—rectum cancer	0.000581	0.00101	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—TYMS—rectum cancer	0.000572	0.00099	CbGpPWpGaD
Cytarabine—CDA—Metabolism—TYMS—rectum cancer	0.000523	0.000906	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TYMS—rectum cancer	0.00052	0.0009	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—rectum cancer	0.000448	0.000776	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—rectum cancer	0.000398	0.00069	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—TYMS—rectum cancer	0.000324	0.000562	CbGpPWpGaD
Cytarabine—DCK—Metabolism—TYMS—rectum cancer	0.000305	0.000528	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TP53—rectum cancer	0.00025	0.000434	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TP53—rectum cancer	0.000242	0.000419	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—HRAS—rectum cancer	0.000199	0.000344	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—HRAS—rectum cancer	0.000185	0.000321	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TP53—rectum cancer	0.000172	0.000299	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—HRAS—rectum cancer	0.000152	0.000264	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—HRAS—rectum cancer	0.000142	0.000246	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—TYMS—rectum cancer	0.000121	0.000209	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—TYMS—rectum cancer	0.000113	0.000195	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—TYMS—rectum cancer	4.07e-05	7.04e-05	CbGpPWpGaD
